| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 24,365 | 24,156 | 22,094 | 22,385 | | Cost of Revenue | 6,797 | 7,030 | 7,769 | 8,107 | | | Gross Profit |
-
| 17,126 | 14,325 | 14,278 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| 360 | | Selling General and Administrative | 10,811 | 12,178 | 11,276 | 10,468 | | Non Recurring |
-
|
-
|
-
| 65,191 | | Others | 3,851 | 1,659 | 6,594 | 1,968 | | | | Total Operating Expenses |
-
|
-
|
-
| 77,987 | | | | Operating Income or Loss |
-
| 3,289 | (3,545) | (63,709) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,906 | 3,289 | (3,545) | (63,709) | | Interest Expense | 1,506 | 1,558 | 1,718 | 2,049 | | Income Before Tax | 1,400 | 1,731 | (5,263) | (65,758) | | Income Tax Expense | (2,143) | 382 | (800) | (3,680) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,543 | 1,349 | (4,463) | (62,078) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,543 | 1,349 | (4,463) | (62,078) | | Preferred Stock And Other Adjustments | (590) | (587) | (587) |
-
| | | Net Income Applicable To Common Shares | $2,953 | $762 | ($5,050) | ($62,078) |
|
0.03% Nasdaq 
Income Statement
